Going anti-Viral

Episode 2 - Latest Update on Urgent Virus Outbreaks, August 2023 Dialogue on Urgent Viral Diseases

November 10, 2023 Going Anti-Viral Season 1 Episode 2
Episode 2 - Latest Update on Urgent Virus Outbreaks, August 2023 Dialogue on Urgent Viral Diseases
Going anti-Viral
More Info
Going anti-Viral
Episode 2 - Latest Update on Urgent Virus Outbreaks, August 2023 Dialogue on Urgent Viral Diseases
Nov 10, 2023 Season 1 Episode 2
Going Anti-Viral

Episode 2 - Latest Update on Urgent Virus Outbreaks, August 2023 Dialogue on Urgent Viral Diseases    

 This episode of Going anti-Viral features an IAS–USA Dialogue titled "Latest Update on Urgent Virus Outbreaks," which is a panel discussion held on August 1, 2023. 

Dr Paul A. Volberding from the University of California San Francisco serves as the moderator and welcomes three distinguished panelists: Dr Carlos del Rio from Emory University, Yvonne Maldonado from Stanford University and Dr Michael Saag from the University of Alabama Birmingham. discuss recent developments in COVID-19, MPOX, RSV, and HIV. This includes the the paradigm-shifting results of the REPRIEVE study, current hurdles in COVID-19 vaccination and antiviral treatment, and trends in RSV and MPOX. They also discuss the overall impact of COVID-19 on education and child development.


 00:08 Introduction and Panel Discussion Overview
 01:56 Discussion on the REPRIEVE Study
 05:59 COVID-19 Updates and Vaccination Challenges
 13:35 The Role of Antivirals in COVID-19 Treatment
 20:39 Future of COVID-19 Vaccines and Age Group Considerations
 27:20 The Importance of Transparency

28:18 The Need for Open Discussions on COVID-19 Vaccines
 29:47 The Existential Threat to Science-Based Medicine
 31:49 The Challenge of Testing for RSV
 33:11 The Potential Impact of RSV Vaccines
 36:45 The Ongoing Struggle with Long COVID-19
 42:46 The Increasing Cases of MPOX
 48:27 The Tragic Impact of the Pandemic on Education
 53:42 The Importance of In-Person Interactions
 54:10 Closing Remarks
 

__________________________________________________

Produced by IAS-USA, Going anti–Viral is a podcast for clinicians involved in research and care in HIV, its complications, and other viral infections. This podcast is intended as a technical source of information for specialists in this field, but anyone listening will enjoy learning more about the state of modern medicine around viral infections.

Going anti-Viral’s host is Dr Michael Saag, a physician, prominent HIV researcher at the University of Alabama at Birmingham, and volunteer IAS–USA board member. In most episodes, Dr Saag interviews an expert in infectious diseases or emerging pandemics about their area of specialty and current developments in the field. Other episodes are drawn from the IAS–USA vast catalogue of panel discussions, Dialogues, and other audio from various meetings and conferences.

Email podcast@iasusa.org to send feedback, show suggestions, or questions to be answered on a later episode.

Follow Going anti-Viral on:
Apple Podcasts
YouTube
Instagram
TikTok
...

Show Notes

Episode 2 - Latest Update on Urgent Virus Outbreaks, August 2023 Dialogue on Urgent Viral Diseases    

 This episode of Going anti-Viral features an IAS–USA Dialogue titled "Latest Update on Urgent Virus Outbreaks," which is a panel discussion held on August 1, 2023. 

Dr Paul A. Volberding from the University of California San Francisco serves as the moderator and welcomes three distinguished panelists: Dr Carlos del Rio from Emory University, Yvonne Maldonado from Stanford University and Dr Michael Saag from the University of Alabama Birmingham. discuss recent developments in COVID-19, MPOX, RSV, and HIV. This includes the the paradigm-shifting results of the REPRIEVE study, current hurdles in COVID-19 vaccination and antiviral treatment, and trends in RSV and MPOX. They also discuss the overall impact of COVID-19 on education and child development.


 00:08 Introduction and Panel Discussion Overview
 01:56 Discussion on the REPRIEVE Study
 05:59 COVID-19 Updates and Vaccination Challenges
 13:35 The Role of Antivirals in COVID-19 Treatment
 20:39 Future of COVID-19 Vaccines and Age Group Considerations
 27:20 The Importance of Transparency

28:18 The Need for Open Discussions on COVID-19 Vaccines
 29:47 The Existential Threat to Science-Based Medicine
 31:49 The Challenge of Testing for RSV
 33:11 The Potential Impact of RSV Vaccines
 36:45 The Ongoing Struggle with Long COVID-19
 42:46 The Increasing Cases of MPOX
 48:27 The Tragic Impact of the Pandemic on Education
 53:42 The Importance of In-Person Interactions
 54:10 Closing Remarks
 

__________________________________________________

Produced by IAS-USA, Going anti–Viral is a podcast for clinicians involved in research and care in HIV, its complications, and other viral infections. This podcast is intended as a technical source of information for specialists in this field, but anyone listening will enjoy learning more about the state of modern medicine around viral infections.

Going anti-Viral’s host is Dr Michael Saag, a physician, prominent HIV researcher at the University of Alabama at Birmingham, and volunteer IAS–USA board member. In most episodes, Dr Saag interviews an expert in infectious diseases or emerging pandemics about their area of specialty and current developments in the field. Other episodes are drawn from the IAS–USA vast catalogue of panel discussions, Dialogues, and other audio from various meetings and conferences.

Email podcast@iasusa.org to send feedback, show suggestions, or questions to be answered on a later episode.

Follow Going anti-Viral on:
Apple Podcasts
YouTube
Instagram
TikTok
...